Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liewei Wang

Showing results (251-260 of 277) with videos related to

Pageof 28
Sort By:
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2018
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto StudyPeter A Fasching, Sibylle Loibl, Chunling Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Breast Cancer Research : BCR|June 10, 2024
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancerRoberto A Leon-Ferre, Kaitlyn R Whitaker, Vera J Suman, et al.
JAMA|August 26, 2020
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical TrialNaveen L Pereira, Michael E Farkouh, Derek So, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2020
Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor αJames N Ingle, Junmei Cairns, Vera J Suman, et al.
Translational Psychiatry|January 11, 2018
Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomicsDuan Liu, Balmiki Ray, Drew R Neavin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast CancerDiana C West, Masha Kocherginsky, Eva Y Tonsing-Carter, et al.
Plos Biology|January 24, 2020
Knowledge-guided analysis of "omics" data using the KnowEnG cloud platformCharles Blatti, Amin Emad, Matthew J Berry, et al.
The Journal of Clinical Investigation|June 8, 2021
FOXA1 overexpression suppresses interferon signaling and immune response in cancerYundong He, Liguo Wang, Ting Wei, et al.
Pageof 28

Showing results (251-260 of 277) with videos related to

Sort By:
Pageof 28
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2018
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto StudyPeter A Fasching, Sibylle Loibl, Chunling Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2023
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate CancerJamie M Sperger, Kyle T Helzer, Charlotte N Stahlfeld, et al.
Breast Cancer Research : BCR|June 10, 2024
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancerRoberto A Leon-Ferre, Kaitlyn R Whitaker, Vera J Suman, et al.
JAMA|August 26, 2020
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical TrialNaveen L Pereira, Michael E Farkouh, Derek So, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2020
Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor αJames N Ingle, Junmei Cairns, Vera J Suman, et al.
Translational Psychiatry|January 11, 2018
Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomicsDuan Liu, Balmiki Ray, Drew R Neavin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast CancerDiana C West, Masha Kocherginsky, Eva Y Tonsing-Carter, et al.
Plos Biology|January 24, 2020
Knowledge-guided analysis of "omics" data using the KnowEnG cloud platformCharles Blatti, Amin Emad, Matthew J Berry, et al.
The Journal of Clinical Investigation|June 8, 2021
FOXA1 overexpression suppresses interferon signaling and immune response in cancerYundong He, Liguo Wang, Ting Wei, et al.
Pageof 28